Snf5 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Snf5, a core subunit of the SWI/SNF chromatin remodeling complex, which plays a crucial role in regulating gene expression by altering chromatin structure. Snf5, also known as SMARCB1 or INI1, is essential for the proper functioning of the SWI/SNF complex, which uses ATP hydrolysis to reposition, eject, or restructure nucleosomes, thereby modulating the accessibility of DNA to transcription factors and other regulatory proteins. This process is fundamental for the regulation of various cellular processes, including transcription, DNA repair, replication, and cell differentiation. Snf5 acts as a scaffolding protein within the SWI/SNF complex, facilitating the assembly and stability of the complex and ensuring its proper targeting to specific genomic regions. By inhibiting Snf5, researchers can disrupt the activity of the SWI/SNF complex, providing a powerful tool to study the specific contributions of Snf5 to chromatin remodeling and the regulation of gene expression.
In research settings, Snf5 inhibitors are valuable tools for exploring the molecular mechanisms by which the SWI/SNF complex regulates chromatin structure and the broader implications of its activity on cellular function and development. By blocking Snf5 activity, scientists can investigate how the inhibition affects the ability of the SWI/SNF complex to remodel chromatin, particularly focusing on the impact on gene expression, chromatin accessibility, and the regulation of key developmental pathways. This inhibition allows researchers to study the downstream effects on cellular processes such as differentiation, proliferation, and response to environmental signals, where SWI/SNF-mediated chromatin remodeling plays a critical role. Additionally, Snf5 inhibitors provide insights into the interactions between Snf5 and other components of the SWI/SNF complex, as well as its role in coordinating the activities of other chromatin-associated factors. Through these studies, the use of Snf5 inhibitors enhances our understanding of the fundamental role of chromatin remodeling in gene regulation, the maintenance of cellular identity, and the broader implications of SWI/SNF activity in cellular homeostasis and development.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
HDAC inhibitor that can modify chromatin structure. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Another HDAC inhibitor affecting chromatin conformation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BRD proteins, altering chromatin reader functions. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Targets BRD proteins, influencing chromatin interactions. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
Histone acetyltransferase p300 inhibitor. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
HDAC inhibitor that can influence chromatin accessibility. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
HDAC3-specific inhibitor, altering specific chromatin modifications. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Inhibits histone acetyltransferases, impacting chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
HDAC inhibitor with potential effects on chromatin remodeling. | ||||||